EMA (EU)
EVENT
Committee for Orphan Medicinal Products (COMP): 8-10 September 2026
Published: 9/10/2026Detected: 7/18/2026
Summary preview
Schedules the COMP meeting (8–10 September 2026) at the European Medicines Agency in Amsterdam to support review of applications for orphan medicinal product designation for rare-disease medicines.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountrare_diseases
clinical
safety
quality
labeling
manufacturing
#COMP
#orphan medicinal product designation
#rare diseases
#EMA
#designation application
Official Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 202611/23/2026
- Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines11/20/2026
- EMA annual call with General Practitioner Organisations' representatives11/20/2026
- Digitalisation and artificial intelligence in pharmaceutical manufacturing: Quality Innovation Group (QIG) - Follow-up roundtable meeting11/18/2026
- Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 202611/18/2026